| Pharmaceutical active ingredients: |
| Metformin HydrochlorideRosiglitazone Maleate |
| Available forms, composition and doses of Rosicon MF: |
| N / A |
| Rosicon MF medical category: |
| Human:Antidiabetic agentsBiguanidesThazolidinediones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BD03 - Metformin and Rosiglitazone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Glenmark Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Walaphage PZ | Metformin Hydrochloride; Pioglitazone Hydrochloride | Wallace Pharmaceuticals |
| ZolidPlus | Metformin Hydrochloride; Pioglitazone Hydrochloride | Getz Pharma |
| PrandiMet | Metformin Hydrochloride; Repaglinide | Novo Nordisk |
| AvandaMet | Metformin Hydrochloride; Rosiglitazone Maleate | GlaxoSmithKline; Firma Chun Cheong; SB Pharmco; Zuellig Pharma |
| Roglin-M | Metformin Hydrochloride; Rosiglitazone Maleate | Aristo Pharmaceuticals |
| Rosiglitazone; Metformin | Metformin Hydrochloride; Rosiglitazone Maleate | Teva |
| Kombiglyze XR | Metformin Hydrochloride; Saxagliptin | Bristol-Myers Squibb; AstraZeneca |
| Badefem | Metformin Hydrochloride; Sibutramine Hydrochloride | Nucitec |
| Janumet | Metformin Hydrochloride; Sitagliptin Phosphate | Merck; DKSH; Four Star; Zuellig Pharma |
| Velmetia | Metformin Hydrochloride; Sitagliptin Phosphate Monohydrate | Pierre Fabre |